Geraldine Henwood, Director at MAP Pharmaceuticals, Inc. (MAPP), sold 5,240 shares at $15.00 ($79K) on 2012-11-23, disclosed to the SEC on 2012-11-27.
Scheduled sale ($79k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.00 | 1,490 | $22K | 28.4% |
| 2 | $15.00 | 3,750 | $56K | 71.6% |
| Total | $15.00 avg | 5,240 | $79K | 100% |
| Filing → |
| BXRX | BUY | 2021-05-10 | $5K | — | Filing → |
| REPH | SELL | 2020-04-20 | $658K | — | Filing → |
| REPH | SELL | 2019-05-15 | $1.5M | — | Filing → |